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Abstract
Background:  Chromosomal copy number changes (aneuploidies) play a key role in cancer
progression and molecular evolution. These copy number changes can be studied using microarray-
based comparative genomic hybridization (array CGH) or gene expression microarrays. However,
accurate identification of amplified or deleted regions requires a combination of visual and
computational analysis of these microarray data.
Results: We have developed ChARMView, a visualization and analysis system for guided discovery
of chromosomal abnormalities from microarray data. Our system facilitates manual or automated
discovery of aneuploidies through dynamic visualization and integrated statistical analysis.
ChARMView can be used with array CGH and gene expression microarray data, and multiple
experiments can be viewed and analyzed simultaneously.
Conclusion:  ChARMView is an effective and accurate visualization and analysis system for
recognizing even small aneuploidies or subtle expression biases, identifying recurring aberrations in
sets of experiments, and pinpointing functionally relevant copy number changes. ChARMView is
freely available under the GNU GPL at http://function.princeton.edu/ChARMView.
Background
Aneuploidies (chromosomal copy number changes) con-
stitute a key mechanism in cancer progression [1,2] and
play important evolutionary roles in speciation [3] and
adaptive mutation in yeast and microbial populations
[4,5]. Array-based comparative genomic hybridization
(array CGH) has enabled fast genome-wide investigations
of copy-number changes [6,7]. However, once microarray
experiments have been performed, accurate identification
of amplifications and deletions requires a combination of
manual discovery through data visualization and sophis-
ticated statistical analysis.
Computational methods can use additional data sources,
such as gene expression, to facilitate the discovery and
analysis of genomic aberrations. This is possible because
the presence of amplifications or deletions of whole or
partial chromosomes can have substantial effects on gene
expression in the affected regions [8-10]. Gene expression
microarray data can serve both as a second source of infor-
mation for aneuploidy detection and perhaps as an indi-
cation of which genomic changes are most functionally
relevant since mRNA transcript abundance more directly
affects cellular phenotype than genomic DNA content.
Therefore, an effective visualization and analysis system
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for aneuploidy detection should make use of both array
CGH and gene expression data, and allow easy examina-
tion of overlaps in the corresponding data sets.
Existing visualization tools include Caryoscope [11],
CGHAnalyzer [12], Java Treeview's Karyoscope [13], and
SeeCGH [14]. All of these were developed specifically for
the analysis of array CGH data and with the exception of
CGHAnalyzer, none allow convenient visualization of
multiple experiments. Additionally, while they all offer a
number of useful approaches to visualization, none
include automatic statistical prediction to complement
manual discovery of amplifications and deletions (see
Table 1 for a detailed comparison of features of our soft-
ware as compared to those of existing applications). To
facilitate discovery of genomic aberrations from microar-
Table 1: Comparison with existing visualization and analysis software. Comparison of ChARMView's functionality with existing 
visualization and analysis software including Caryoscope [11], CGHAnalyzer [12], Java Treeview's Karyoscope [13], SeeCGH [14], 
CGH-Explorer [24], CGH-PRO [25], and CGH-Miner [26].
Feature ChARM View Caryo-scope TreeView 
(Karyosco 
pe)
SeeGH CGH 
Analyzer
CGH 
Explorer
CGH PRO CGH Miner
Platform most platforms 
(Java-based)
most platforms 
(Java-based)
most platforms 
(Java-based)
Windows most platforms 
(Java-based)
most platforms 
(Java-based)
Linux, 
Windows
Windows, 
Unix, Excel 
add-in
Software 
availability
freely 
downloadable 
with
registration
freely 
downloadable
freely 
downloadable
freely 
downloadable 
with 
registration
freely 
downloadable 
with 
registration
freely 
downloadable 
with 
registration
freely 
downloadable
freely 
downloadable 
with 
registration
Source-code 
license
GNU GPL MIT license GNU GPL not available freely 
downloadable
freely 
downloadable
GNU GPL freely 
downloadable
External 
software 
dependencies
none none none requires 
MySQL 
database
none none MySQL, R R
Automatic 
statistical 
determinatio
n of single-
array 
aberrations
Yes No No No No Yes Yes Yes
Statistical 
analysis of 
manually 
selected 
regions
Yes No No No Yes Yes No No
Simultaneous 
display of 
multiple 
experiments
Yes No No No Yes Yes Yes Yes
Statistical 
analysis of 
aberrations 
occurring in 
multiple 
experiments
No No No No Yes No No No
Aberration 
breakpoints/
statistics 
export
Yes No No No Yes Yes Yes Yes
Image export Yes Yes Yes Yes Yes Yes Yes Yes
Command-
line statistical 
analysis 
feature
Y e sN oN oN oN oN oN oN o
Allows user-
defined 
genomic 
feature 
annotation
Yes Yes Yes Yes Yes Yes Yes Yes
Web-linked 
genomic 
feature 
annotation
No Yes Yes Yes Yes Yes Yes NoBMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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ray data, novel methodology is required that integrates
visualization with sophisticated statistical analysis and
enables visualization of multiple experiments and data
types simultaneously.
Here we describe ChARMView – an integrated system that
combines statistical analysis with effective visualization
capabilities to enable interpretation of microarray data for
aneuploidy discovery. Our system facilitates both manual
and automated discovery of genomic aberrations from
microarray data and can display multiple experiments and
data types simultaneously. ChARM-View can be used to
identify amplifications and deletions from array CGH or
gene expression data independently or simultaneously,
making it a powerful approach for identifying real and
functionally relevant chromosomal changes.
Implementation
ChARMView was implemented in Java using Swing set
components to ensure cross-platform compatibility.
Many of the visualization features were developed using
the Open Source 2D graphics toolkit Piccolo developed at
the University of Maryland [15].
Results and Discussion
Methodology: statistical analysis
ChARMView computational analysis automatically
detects regions of non-random spatial bias and is appro-
priate for any genomic data associated with chromosomal
coordinates. Statistical analysis is based on our algorithm
ChARM (Chromosomal Aberration Region Miner),
described in detail in [16]. ChARM identifies potential
breakpoints by a differential filter followed by an accurate
expectation-maximization approach. The statistical signif-
icance of each identified region is evaluated with a one-
sample sign test and a permutation-based mean test. By
their formulation, the significance tests are valid for any
size segment, but do lose power with decreasing segment
size. ChARM has been evaluated on gene expression and
array CGH data: it is robust and accurate for regions as
small as 4–5 probes, and sensitive enough to detect aneu-
ploidies even in mixed populations of cells [16].
As a system for dynamic and real-time data analysis and
visualization, ChARMView requires very fast statistical
algorithms. However, the permutation-based test as origi-
nally described in Myers et al. [16] requires non-trivial
computation since it involves performing several thou-
sand permutations of the chromosome order. To speed up
the mean permutation test for the software system, we
have developed an accurate approximation that requires
many fewer permutations. The original version of the test
requires computing the mean of the region of interest and
comparing this with the means of similar-sized segments
in randomly permuted data. We have verified that means
of typical chromosomal segments in array CGH and gene
expression data can generally be reasonably approximated
with a normal distribution. This is a generally well-
accepted claim even for small groups (~10) unless the
underlying population is extremely non-normal, which is
typically not the case for log-transformed array CGH or
gene expression data. The statistical significance of pre-
dicted aneuploidy region in ChARMView is obtained by
computing means of 200 permutations of chromosome
ordering of the actual data, estimating the parameters, and
then integrating the tail of the underlying distribution
beyond the observed value. Figure 1 illustrates the corre-
lation between p-values generated from 10,000 random
permutations and p-values obtained from a normal
approximation whose parameters were estimated with
only 200 permutations. This approximation yields the
precision of several thousand permutations based on sig-
nificantly less computation. Completing a fully auto-
mated statistical analysis on a typical gene expression
dataset (6000 genes over 16 chromosomes, measured in
16 experiments) requires approximately 7 seconds/exper-
iment for a total of less than 2 minutes on a Pentium 4 3.2
GHz desktop. ChARMView also allows users to manually
select regions to test for statistical significance.
Methodology: visualization-based analysis
The most powerful aspect of ChARMView is integration of
computational analysis with visualization. This combina-
tion of visualization and analysis enables users to view
automated predictions of aneuploidies as well as analyze
statistical significance of manually selected regions. Visu-
alization is a critical complement to computational anal-
ysis as human perception can often identify subtle trends
in the data that cannot be detected with purely computa-
tional methods. This is especially critical when comparing
results of multiple experiments or experimental replicates,
such as in cancer studies where researchers often search
for recurring aneuploidies in a set of patients. ChARM-
View facilitates such discovery with visualization of mul-
tiple experimental replicates, experiments, and data types.
The most common way to increase confidence in results
of an experiment is to produce replicate microarray exper-
iments. Data from such replicate experiments is usually
averaged for computational analysis. However, viewing
such replicates simultaneously is an effective approach to
analysis, as people are often perceptive of subtle but
repeated trends that are difficult to capture with a statisti-
cal test. This visualization-based approach does not make
any assumptions, such as independence assumption of
the typically used Fisher meta-analysis test [17]. Thus,
aligning corresponding chromosomal data from several
replicates of the same experiment typically allows the user
to spot trends that might otherwise go unnoticed. FigureBMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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2 illustrates this phenomenon with two replicates of the
same array CGH experiment.
The simultaneous display feature of ChARMView is also
useful for visual analysis of computational prediction
results for multiple experiments. This is an effective
method for identifying common genomic aberrations in
otherwise uncorrelated experiments or a characteristic
aberration in a set of samples with a common phenotype.
For example, a set of breast cancer samples [18,19] can
share the same bias in gene expression that corresponds to
a predicted aneuploidy or a localized expression bias, as
shown in Figure 3. Overlapping predictions serve as
independent confirmations that the predicted aberration
is real. Furthermore, results of such analysis of multiple
samples can then be used to correlate specific chromo-
somal aberrations with phenotypic or clinical parameters.
As array CGH techniques become more widely applied,
the generation of copy number data is rarely the end goal
of biological studies. Instead, a key challenge is decipher-
ing which parts of a karyotypic profile are responsible for
particular phenotypes. While sophisticated statistical and
computational methods will certainly be required to
answer these questions, the most effective approaches will
also need to harness the power of human visual percep-
tion. To address this issue, ChARMView can display and
analyze both array CGH and gene expression microarray
Gaussian approximation of the permutation-based p-value Figure 1
Gaussian approximation of the permutation-based p-value. ChARMView performs 200 permutations to assess statis-
tical significance of predictions, then uses Gaussian approximation to estimate the p-value. The p-values based on 200 permuta-
tions and Gaussian approximation show .9991 correlation to the p-values based on 10,000 permutations as computed by 
ChARM.BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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data and display these diverse data and predictions for
corresponding chromosomes simultaneously. Simultane-
ous display of array CGH and gene expression data ena-
bles researchers to observe the effect that amplification or
deletion of particular sequences of genomic DNA has on
the abundance of mRNA transcripts (Figure 4). We have
noted a number of cases where large amplifications or
deletions result in no detectable change in gene expres-
sion. These regions may be less likely to cause a particular
phenotype than aneuploidies that result in drastic
changes in gene expression. ChARMView facilitates con-
venient discovery of these changes, focusing further exper-
imental investigation.
A final unique characteristic of ChARMView is that its vis-
ualization and statistical tools are developed for general
use, independent of data type and organism. Any dataset
with features that can be associated with chromosomal
position can be imported and analyzed with ChARMView.
For instance, the software has been particularly useful in
identification of aneuploidies based on gene expression
datasets although array CGH is the typical experimental
approach for probing genomic amplifications or dele-
tions. ChARMView has also been used to identify spa-
tially-correlated biases in gene expression that are
unrelated to altered chromosome structure. Generally,
our tool can be used to identify any region of non-ran-
domness with respect to position in genomic data with
inherent ordering. In addition to its usefulness for a vari-
ety of data types, ChARMView can be applied to a variety
of organisms. By default, the system provides chromo-
somal coordinates for Saccharomyces cerevisiae data with
ORF identifiers and human data with Unigene identifiers.
However, any data that can be mapped to a set of linear
chromosomes can be imported and analyzed by
ChARMView.
Illustration of application
We have applied ChARMView to a number of array CGH
and gene expression datasets, including data derived from
both  Saccharomyces cerevisiae and human experiments.
Here we present an example application of our software to
array CGH data from experimental evolution experiments
in which eight strains of budding yeast were analyzed for
chromosomal copy number changes after 100–500 gener-
ations of growth in glucose-limited chemostats [5]. Dun-
ham  et al. confirmed aneuploidy regions identified by
array CGH through pulsed-field gel electrophoresis, thus
creating a standard for assessing our results. Our method
identified all 12 of the confirmed aneuploidies and two
additional regions of bias. The novel regions identified by
our method correspond to biases smaller than the ones
identified by Dunham et al. [5] and may reflect aneu-
ploidy present in a subset of cells in the population or
may be due to a hybridization artifact. Further laboratory
experiments are required to further evaluate these predic-
tions. Figure 5 shows a screenshot of our application upon
finishing automated statistical analysis of one of these
experiments.
We also present two specific instances from an array CGH
breast cancer study where ChARMView can be used to vis-
ualize and accurately predict breakpoints of known
amplifications. Figure 6A illustrates the results of ChARM-
View's automated statistical analysis on chromosome 1
array CGH profiles of three different breast tumor samples
(110B, 112B, 122A) from [18]. The entire q arm of chro-
mosome 1 is known to frequently amplified in breast can-
cer (typically observed in approximately 50–60% of
Simultaneous visualization of replicate experiments Figure 2
Simultaneous visualization of replicate experiments. A set of replicate array CGH experiments from Dunham et al. [5] 
displayed with ChARMView (chromosome 4 of CP1AB, replicates 1 and 2 shown). The region identified by the arrows is hard 
to distinguish from noise in either of the replicates when viewed separately, but is clearly a region of positive bias when the 
replicates are viewed together. This is confirmed by statistical analysis.BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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tumors [20,21]). Thus, we expect the amplications here to
begin at or near the centromeric end of the q arm.
ChARMView predicts breakpoints 3, 1, and 0 probes from
the centromeric end of the q arm for samples 110B, 112B,
and 122A respectively.
Simultaneous visualization of multiple independent expression microarrays Figure 3
Simultaneous visualization of multiple independent expression microarrays. Simultaneous visualization of overlap-
ping significant expression biases in a set of four independent breast tumor samples from Sorlie et al. [19] (chromosome 6 of 
breast tumor expression profiles BC208A-BE, BC305A-BE, BC308B-BE, and BC111A-BE shown). Each red bar below the data 
indicates a predicted aberration identified independently on the corresponding experiment.BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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ChARMView can also be used to accurately find much
smaller regions of amplification or deletion and the asso-
ciated breakpoints. Figure 6B illustrates this capability on
chromosome 17 array CGH profiles of three breast tumor
samples (123B, 309A, and BC-A) from [18]. An amplicon
frequently associated with breast tumors includes the
ERBB2 oncogene at 17q12. While breakpoints identified
in individual tumors vary, recent studies have identified a
group of 7 genes surrounding the ERBB2 locus that are
commonly amplified, including NEUROD2,  MLN64,
PNMT, ERBB2, GRB7, ZNFN1A3, and EST 48582 [22,23].
ChARMView's amplification predictions for the three
tumor profiles shown include 15, 18, and 13 probes
respectively, all of which span the 7-gene region previ-
ously identified. All predictions shown in Figure 6 have
Bonferroni-corrected p-values less than .05 for both mean
and sign significance tests. Complete lists of predicted
breakpoints for both chromosome 1 and chromosome 17
amplicons are included in Table 2.
Usage
ChARMView can be downloaded at http://function.princ
eton.edu/ChARMView and run on virtually any platform
if the J2SE Java Runtime Environment version 1.4.2 or
greater is present. A brief overview of the primary features
of the software follows.
Loading data
ChARMView accepts all types of data from any organism
provided that the features can be ordered on a set of linear
chromosomes. Input files must be tab-delimited, specifi-
cally in the commonly-used .pcl format. Chromosome
labels and position must be included in the input file
unless the organism type is Saccharomyces cerevisiae or
human with ORF or Unigene identifiers, which ChARM-
View is able to order without coordinates.
Viewing data
Figure 5 shows a typical ChARMView screenshot upon
loading data and statistical analysis. The data display is
Identifying functionally relevant genomic aberrations Figure 4
Identifying functionally relevant genomic aberrations. A small amplification evident in the array CGH data breast can-
cer data (top) [18], and its effect on mRNA expression (bottom) [19] (chromosome 15 of breast tumor sample 709B shown).BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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zoomable and selectable with mouse-overs for identifica-
tion of experiments and individual genes. Zoom features
include standard single-click magnification, zoom to rec-
tangle, and zoom reset (fit to screen) capabilities. When
one or more gene or probe data points are selected, iden-
tifiers and associated annotation are displayed in the
"Results" tab, which appears adjacent to the display panel.
This allows users to select regions of interest on the dis-
play panel and retrieve lists of genes or probes within
these regions. Additionally, any number of experiments
may be viewed simultaneously by toggling the corre-
sponding checkboxes in the "Experiment Options" tab,
also adjacent to the display panel.
Analyzing data
ChARMView supports two different modes of analysis.
The first employs the automated edge-finding algorithm
discussed in Myers et al. [16] followed by statistical analy-
sis. The second mode is for testing user-selected regions of
data and only evaluates the statistical significance of the
chosen region. Both methods of analysis rely on two tests
of statistical significance: a mean-based permutation test,
and a one-sample sign test. Details of both tests are dis-
cussed above and in Myers et al. [16]. P-values for these
tests are reported for all regions found by the automated
approach or selected by the user. Figure 5 displays a typi-
cal view of statistical results for a single experiment. Note
that the red and green rectangles below the data corre-
spond to regions of predicted aberration. The p-value cut-
off at which results of the statistical analysis appear in the
display panel can be adjusted by applying p-value filters
provided in the "Prediction Options" tab adjacent to the
display panel.
A p-value filter consists of a logical combination of the
mean permutation test and/or the one-sample sign test
and real-valued cutoffs for each test. These combinations
specify how the selected p-value cutoffs will be used to
deem statistical significance. For instance, one possible p-
value filter is "Sign AND Mean Tests" with Sign p-value
cutoff of 0.001 and Mean p-value cutoff of 0.01, which
will result in only predictions with both Bonferroni cor-
Screenshot of ChARMView applied to S. cerevisiae array CGH data Figure 5
Screenshot of ChARMView applied to S. cerevisiae array CGH data. Screenshot of ChARMView analysis of S. cerevi-
siae molecular evolution experiments data from Dunham et al [5]. The right panel displays array CGH data arranged in the 
order of chromosomal position and amplification (red) and deletion (green) predictions. The left panel displays information for 
the selected region, including gene names and values and statistics for the selected amplification prediction.BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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Predicted amplifications and deletions on breast cancer array CGH data Figure 6
Predicted amplifications and deletions on breast cancer array CGH data. ChARMView automated predictions on 
three breast tumor array CGH profiles (110B, 112B, 122A) from chromosome 1 and three profiles (123B, 309A, and BC-A) 
from chromosome 17 of [18]. The predicted chromosome 1 breakpoints (identified by arrows in Figure 6A) are 3, 1, and 0 
probes from the centromere. The predicted chromosome 17 amplification common to all three profiles (identified by arrows 
in Figure 6B) includes 7 genes known to be typically amplified with the ERBB2 locus. All visible predictions have Bonferroni-cor-
rected p-values less than .05 for both mean and sign significance tests. See Table 2 for a complete list of breakpoint predictions 
for each of the results pictured.BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
Page 10 of 11
(page number not for citation purposes)
rected sign p-values of less than .001 and mean p-values
of .01 being displayed. The Bonferroni corrected p-value is
obtained by multiplying the raw p-value from both signif-
icance tests by the number of regions tested for that chro-
mosome. Another possibility is to apply "Sign OR Mean
Tests", which results in a prediction being displayed if at
least one of these criteria is met at the specified signifi-
cance level. While we recommend the "Sign AND Mean
Test" option for general use, other combinations may be
useful under certain circumstances. Users can select any
displayed prediction, which results in the genes or probes
and associated annotation in that particular region to be
displayed in the "Results" tab adjacent to the display
panel (Figure 5).
Exporting results
Publication quality images can be exported in multiple
formats at any stage of the visualization. This includes
images of exclusively raw data, results of statistical analy-
sis, or combinations of these. In addition, predictions
resulting from automated or manual statistical analysis
can be exported in tab-delimited text form with the
associated gene or probe identifiers and corresponding p-
values. A p-value filter similar to that described in
"Analyzing data" can be applied to all exported results to
allow full user control over which predictions are
included. Finally, lists of genes or probes for any object
selected on the display panel can also be exported to text
files to facilitate immediate analysis of regions identified
by manual inspection.
Command-line usage
ChARMView can also be used in command-line mode to
make automated predictions of amplification or
deletions. This command-line feature can be used by
invoking ChARMView as follows:
java -Xmx300m -jar ChARM.jar
-inputFile <input-file>
-outputFile <output-file>
-organismType <organism-type>
-meanPvalCutoff <mean-pvalue-cutoff>
-signPvalCutoff <sign-pvalue-cutoff>
-sigTestType <significance-test-type>
The possible organism types, which determine reference
chromosomal coordinates, are: 1, Saccharomyces cerevisiae;
2, human; 3, other (user-provided coordinates). Possible
significance test options include: 1, mean AND sign tests;
2-mean OR sign tests; 3, mean test only; 4, sign test only.
When run in command-line mode, ChARMView outputs
all predicted regions of amplification and deletion meet-
ing the specified significance level.
Conclusion
We have developed ChARMView, a statistical visualiza-
tion system for analysis and discovery of genomic aberra-
tions. Our system can analyze various types of genomic
data, including gene expression and array CGH microar-
ray data, for a variety of organisms, and has been devel-
oped to facilitate both manual discovery through
powerful visualization as well as automated prediction
through robust statistical analysis. ChARMView can iden-
tify and visualize even small copy number changes, and is
sensitive enough to detect aneuploidies in mixed popula-
tions of cells. This combination makes ChARMView
uniquely effective for identifying subtle trends, recurring
aberrations in sets of experiments, and pinpointing func-
tionally relevant copy number changes. Thus, this system
is effective for identification of aneuploidies in cancer
studies and molecular evolution experiments, as well as
for routine analysis of microarray data for special biases.
Table 2: Examples of predicted breakpoints in breast tumor aCGH case study. Listing of Unigene IDs corresponding to predicted 
breakpoints for ChARMView results pictured in Figures 6A and 6B. The Unigene ID and gene name are the first and last markers 
included in the predicted amplification. All results listed have Bonferroni-corrected less than p-values of .05 for both mean and sign 
significance tests.
Tumor sample Chrom. Predicted start 
breakpoint
Adjacent gene (in 
amplicon)
Predicted end 
breakpoint
Adjacent gene (in 
amplicon)
110B 1 Hs.15871 ACP6 Hs.7395 (last marker) TFB2M
112B 1 Hs.59889 HMGCS2 Hs.7395 (last marker) TFB2M
122A 1 Hs.381235 SEC22L1 Hs.7395 (last marker) TFB2M
123B 17 Hs.97477 LYZL6 Hs.276916 NR1D1
309A 17 Hs.73817 CCL18 Hs.267871 PTRF1
BC-A 17 Hs.635 CACNB1 Hs.2340 HAP1BMC Bioinformatics 2005, 6:146 http://www.biomedcentral.com/1471-2105/6/146
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Availability and requirements
Project name: ChARMView
Project homepage: http://function.princeton.edu/
ChARMView
Operating system(s): Platform independent
Programming language: Java
Other requirements: J2SE Java Runtime Environment
1.4.2 or higher
License: GNU GPL
Any restrictions to use by non-academics: None
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